126 related articles for article (PubMed ID: 6167572)
1. Immunochemical mapping of the conformation of human fibrinogen. The gamma 95-264 segment in inaccessible to antibody in native fibrinogen but progressively exposed by plasmic cleavage.
Fair DS; Edgington TS; Plow EF
J Biol Chem; 1981 Aug; 256(15):8018-23. PubMed ID: 6167572
[TBL] [Abstract][Full Text] [Related]
2. Conformation of the carboxy-terminal region of the A alpha chain of fibrinogen as elucidated by immunochemical analyses.
Cierniewski CS; Plow EF; Edgington TS
Eur J Biochem; 1984 Jun; 141(3):489-96. PubMed ID: 6204869
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain.
Plow EF; Edgington TS
J Immunol; 1986 Sep; 137(6):1910-5. PubMed ID: 2943807
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.
Plow EF; Edgington TS
J Clin Invest; 1975 Dec; 56(6):1509-18. PubMed ID: 53241
[TBL] [Abstract][Full Text] [Related]
5. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
Brenner B; Francis CW; Marder VJ
J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
[TBL] [Abstract][Full Text] [Related]
6. Internalization of the amino terminal 1-78 sequence of the gamma chain of native fibrinogen and exposure associated with catabolism and plasmin cleavage.
Cierniewski CS; Edgington TS
Biochim Biophys Acta; 1979 Sep; 580(1):32-43. PubMed ID: 94836
[TBL] [Abstract][Full Text] [Related]
7. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
[TBL] [Abstract][Full Text] [Related]
8. Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage.
Edgington TS; Plow EF
J Biol Chem; 1975 May; 250(9):3393-8. PubMed ID: 47328
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
Marder VJ; Budzynski AZ; Barlow GH
Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
[TBL] [Abstract][Full Text] [Related]
10. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
Ferguson EW; Fretto LJ; McKee PA
J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
[TBL] [Abstract][Full Text] [Related]
11. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen.
Plow EF; Gramse M; Havemann K
J Lab Clin Med; 1983 Dec; 102(6):858-69. PubMed ID: 6227673
[TBL] [Abstract][Full Text] [Related]
13. Conformational equilibria in the gamma chain COOH terminus of human fibrinogen.
Cierniewski CS; Budzynski AZ
J Biol Chem; 1987 Oct; 262(29):13896-901. PubMed ID: 3654644
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
[TBL] [Abstract][Full Text] [Related]
15. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
Plow E; Edgington TS
J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of fibrinogen derivatives with antisera to human fibrin D-dimer and its gamma-gamma chain remnant.
Cierniewski CS; Janiak A; Nowak P; Augustyniak W
Thromb Haemost; 1982 Aug; 48(1):33-7. PubMed ID: 7135342
[TBL] [Abstract][Full Text] [Related]
17. Plasmic degradation of fibrinogen Paris I.
Budzynski AZ; Marder VJ
J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
[TBL] [Abstract][Full Text] [Related]
19. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
Cierniewski CS; Kloczewiak M; Budzynski AZ
J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
[TBL] [Abstract][Full Text] [Related]
20. Markers of fibrinogen derivatives used in clinical investigation.
Soria J; Soria C; Mirshahi M; Samama MM
Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
